| 发明名称 |
1,8-naphthyridine derivatives as antidiabetics. |
| 摘要 |
The invention relates generally to naphthyridine derivatives of the formula wherein one of U, X, Y and Z is nitrogen and the others are C-R, where R is hydrogen or a substituent. More specifically, the invention relates to 1,8-naphthyridine derivatives and pharmaceutical compositions containing such derivatives. Methods of the invention comprise administration of a naphthyridine derivative of the invention for the treatment of diabetes and related disorders. |
| 申请公布号 |
ZA200403063(B) |
申请公布日期 |
2005.04.22 |
| 申请号 |
ZA20040003063 |
申请日期 |
2004.04.22 |
| 申请人 |
BAYER PHARMACEUTICALS CORPORATION |
发明人 |
YAMIN WANG;DAVID E. GUNN;QINGJIE LIU;SIDNEY X. LIANG;WILLIAM H. BULLOCK;DONGLEI LIU;MAGNUSON, STEVEN R.;TINDY LI;ERIC S. MULL;JILL E. WOOD;NING QI |
| 分类号 |
A61K31/133;A61K31/155;A61K31/195;A61K31/198;A61K31/435;A61K31/4375;A61K31/44;A61K31/4439;A61K31/444;A61K31/445;A61K31/4453;A61K31/4545;A61K31/455;A61K31/4709;A61K31/4725;A61K31/4745;A61K31/496;A61K31/5355;A61K31/5377;A61K31/541;A61K31/64;A61K31/7034;A61K38/22;A61K38/28;A61K45/00;A61K45/06;A61P3/04;A61P3/10;A61P5/12;A61P5/42;A61P9/12;A61P35/00;A61P37/06;A61P43/00;C07D471/02;C07D471/04 |
主分类号 |
A61K31/133 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
